<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article" xml:lang="EN"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Mol Vis</journal-id><journal-id journal-id-type="publisher-id">MV</journal-id><journal-title>Molecular Vision</journal-title><issn pub-type="epub">1090-0535</issn><publisher><publisher-name>Molecular Vision</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">117</article-id><article-id pub-id-type="publisher-id">2009molvis0092</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Coding variant Met72Thr in the <italic>PEDF</italic> gene and risk of neovascular age-related macular degeneration and polypoidal choroidal vasculopathy</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Bessho</surname><given-names>Hiroaki</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Kondo</surname><given-names>Naoshi</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Honda</surname><given-names>Shigeru</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Kuno</surname><given-names>Shin-ichi</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>Negi</surname><given-names>Akira</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><aff id="aff1"><label>1</label>Department of Surgery, Division of Ophthalmology, Kobe University Graduate School of Medicine, Kobe, Japan</aff><aff id="aff2"><label>2</label>Translational Research Informatics Center, Foundation for Biomedical Research and Innovation, Kobe, Japan</aff><aff id="aff3"><label>3</label>Clinical Genome Informatics Center, Kobe University Graduate School of Medicine, Kobe, Japan</aff></contrib-group><author-notes><corresp id="cor1">Correspondence to: Naoshi Kondo, Department of Surgery, Division of Ophthalmology, Kobe University Graduate School of Medicine, 7-5-2 Kusunoki-cho, Chuo-ku, Kobe 650-0017, Japan; Phone: +81-78-382-6048; FAX: +81-78-382-6059; email: <email xlink:href="nskondo@gmail.com">nskondo@gmail.com</email></corresp></author-notes><pub-date pub-type="collection"><year>2009</year></pub-date><pub-date pub-type="epub"><day>02</day><month>6</month><year>2009</year></pub-date><volume>15</volume><fpage>1107</fpage><lpage>1114</lpage><history><date date-type="received"><day>26</day><month>3</month><year>2009</year></date><date date-type="accepted"><day>26</day><month>5</month><year>2009</year></date></history><permissions><copyright-year>2009</copyright-year><copyright-holder>Molecular Vision</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/3.0/"><p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p></license></permissions><abstract><sec><title>Purpose</title><p>Using a candidate-gene approach, a recent case-control study identified a previously unknown association between neovascular age-related macular degeneration (AMD) and the coding Met72Thr variant in the pigment epithelium-derived factor (PEDF) gene in a Taiwan Chinese population. However, a subsequent replication study failed to see this association in a white European population. We noted an important difference in the sample ascertainment scheme between these two studies. The original study did not consider findings of indocyanine green (ICG) angiography for disease classification, which is the only way to obtain a clear image of polypoidal choroidal vasculopathy (PCV) lesions. This suggests that their cohort might include a considerable amount of PCV, given its high prevalence in the Chinese population. In contrast, the replication study intentionally excluded PCV from the case cohort on the basis of ICG angiograms. Therefore, the inconsistent finding might be caused by potential sample heterogeneity between these two studies. In this respect, this association needed to be examined in a case series of clearly defined individuals with neovascular AMD and PCV. The aim of this study was to validate the previously reported association of the <italic>PEDF</italic> Met72Thr variant in a well characterized Japanese population with neovascular AMD and PCV.</p></sec><sec sec-type="methods"><title>Methods</title><p>We genotyped the Met72Thr variant (rs1136287) in 116 patients with neovascular AMD, 140 patients with PCV, and 189 control participants in a Japanese population. Genotyping was performed using TaqMan technology. We tested for an association of this variant with neovascular AMD and PCV separately. We also evaluated population stratification in our study cohort.</p></sec><sec><title>Results</title><p>We found no statistically significant evidence for association between rs1136287 and either neovascular AMD or PCV under any genetic models (trend, genotypic, dominant, and recessive genetic models; p&#x0003e;0.05). Population structure analyses excluded stratification artifact in our study population.</p></sec><sec><title>Conclusions</title><p>We report a lack of association between the <italic>PEDF</italic> Met72Thr variant and either neovascular AMD or PCV in a Japanese population. We conclude that the Met72Thr variant does not play a significant role in the risk of developing neovascular AMD or PCV.</p></sec></abstract><custom-meta-wrap><custom-meta><meta-name>GalleyStatus</meta-name><meta-value>Export to XML</meta-value></custom-meta><custom-meta><meta-name>corr-author</meta-name><meta-value>Kondo</meta-value></custom-meta></custom-meta-wrap></article-meta></front><body><sec sec-type="intro"><title>Introduction</title><p>Age-related macular degeneration (AMD), a leading cause of blindness among older individuals in developed countries [<xref ref-type="bibr" rid="r1">1</xref>], is a heterogeneous group of disorders with variable clinical findings [<xref ref-type="bibr" rid="r2">2</xref>]. It manifests at an early stage with large drusen and pigmentary abnormalities in the retinal pigment epithelium at the macula. With progression to an advanced stage, it presents with geographic atrophy (dry AMD) or exudative maculopathy (wet/neovascular AMD) as the sequela of choroidal neovascularization (CNV).</p><p>Inner choroidal vascular networks ending in polypoidal lesions are the defining feature of polypoidal choroidal vasculopathy (PCV) [<xref ref-type="bibr" rid="r3">3</xref>-<xref ref-type="bibr" rid="r5">5</xref>], which is now clinically classified into a specific type of AMD [<xref ref-type="bibr" rid="r6">6</xref>]. Some clinical and pathological features such as demography [<xref ref-type="bibr" rid="r7">7</xref>], pathology [<xref ref-type="bibr" rid="r8">8</xref>-<xref ref-type="bibr" rid="r10">10</xref>], and manifestation [<xref ref-type="bibr" rid="r7">7</xref>] are common between neovascular AMD and PCV; however, important differences are also noted in clinical behavior [<xref ref-type="bibr" rid="r3">3</xref>], histopathology [<xref ref-type="bibr" rid="r11">11</xref>,<xref ref-type="bibr" rid="r12">12</xref>], and response to therapy [<xref ref-type="bibr" rid="r13">13</xref>,<xref ref-type="bibr" rid="r14">14</xref>]. These commonalities and differences have been a source of much debate as to whether PCV has a common etiology with neovascular AMD or a distinct phenotype reflecting a different etiology [<xref ref-type="bibr" rid="r8">8</xref>-<xref ref-type="bibr" rid="r12">12</xref>,<xref ref-type="bibr" rid="r15">15</xref>]. PCV has a particularly high incidence in Asian populations, accounting for 54.7% of patients with findings suggestive of neovascular AMD in the Japanese population [<xref ref-type="bibr" rid="r7">7</xref>] and 24.5% in the Chinese population [<xref ref-type="bibr" rid="r16">16</xref>], in contrast to only 8 to 13% in European populations [<xref ref-type="bibr" rid="r3">3</xref>]. The phenotypic spectrum of AMD is quite heterogeneous among different ethnicities. Dry AMD is more frequent in European populations than in Asians; the reverse is true for neovascular AMD [<xref ref-type="bibr" rid="r17">17</xref>-<xref ref-type="bibr" rid="r19">19</xref>].</p><p>To date, many studies have reported various gene variants associated with AMD [<xref ref-type="bibr" rid="r20">20</xref>,<xref ref-type="bibr" rid="r21">21</xref>]. However, findings from most studies have been largely inconclusive because of a lack of consistent replication [<xref ref-type="bibr" rid="r20">20</xref>,<xref ref-type="bibr" rid="r21">21</xref>]. Thus far, variants in two genomic regions have been consistently reproducible across multiple ethnic groups, including the complement factor H (<italic>CFH</italic>) gene at chromosome 1q32 [<xref ref-type="bibr" rid="r22">22</xref>-<xref ref-type="bibr" rid="r26">26</xref>] and the <italic>ARMS2</italic> (<italic>LOC387715</italic>)/<italic>HTRA1</italic> locus at 10q26 [<xref ref-type="bibr" rid="r27">27</xref>-<xref ref-type="bibr" rid="r30">30</xref>]. These two loci are associated with all phenotypes of AMD, including early AMD, dry AMD, and neovascular AMD [<xref ref-type="bibr" rid="r25">25</xref>,<xref ref-type="bibr" rid="r27">27</xref>]. Genetic susceptibility to PCV is also strongly associated with the <italic>CFH</italic> gene and the <italic>ARMS2</italic>/<italic>HTRA1</italic> locus [<xref ref-type="bibr" rid="r31">31</xref>,<xref ref-type="bibr" rid="r32">32</xref>], thus indicating that these two loci play a general role in the etiology of variable phenotypes of AMD and PCV. Besides these shared genetic associations, two phenotype-specific associations have been found. These associations are common variants in the elastin gene for PCV [<xref ref-type="bibr" rid="r33">33</xref>] and an allelic variant (Leu412Phe) in the toll-like receptor 3 (<italic>TLR3</italic>) gene for dry AMD [<xref ref-type="bibr" rid="r34">34</xref>]. From the genetic perspective, both general and phenotype-specific pathways may be implicated in the pathophysiology of AMD and PCV. Therefore, to avoid variable findings across studies, attention to disease classification is a key aspect of genetic studies on AMD, as suggested previously [<xref ref-type="bibr" rid="r35">35</xref>].</p><p>Lin et al. [<xref ref-type="bibr" rid="r36">36</xref>] recently reported a previously unknown association between neovascular AMD and the coding Met72Thr (rs1136287) variant in the pigment epithelium-derived factor (<italic>PEDF</italic>) gene in a Taiwan Chinese population. The authors reported that the minor allele T of rs1136287 was significantly associated with increased disease risk, with an odds ratio (OR) of 3.9 under a recessive disease model [<xref ref-type="bibr" rid="r36">36</xref>]. At present, there is no evidence for functional relevance of the Met72Thr variant, nor has any biologic explanation been proposed for this association. Still, there are multiple lines of evidence for the importance of the protein product <italic>PEDF</italic> in the pathogenesis of AMD [<xref ref-type="bibr" rid="r37">37</xref>], and thus, <italic>PEDF</italic> is a reasonable candidate gene for the disease.</p><p>Mattes et al. [<xref ref-type="bibr" rid="r38">38</xref>] subsequently failed to replicate this association in a white European population with neovascular AMD. We noted an important difference in the sample ascertainment scheme between these two studies [<xref ref-type="bibr" rid="r36">36</xref>,<xref ref-type="bibr" rid="r38">38</xref>]. Lin et al. [<xref ref-type="bibr" rid="r36">36</xref>] applied consensus criteria for AMD classification derived from analysis of a white population and did not consider findings of indocyanine green (ICG) angiography for disease classification. ICG angiography is the only way to obtain a clear image of PCV lesions [<xref ref-type="bibr" rid="r3">3</xref>]. The work of Lin et al. suggests that their cohort might include a considerable amount of PCV, given its high prevalence in the Chinese population [<xref ref-type="bibr" rid="r16">16</xref>]. However, Mattes et al. [<xref ref-type="bibr" rid="r38">38</xref>] performed ICG angiography and excluded individuals with PCV from case participants. Since genetic susceptibility to distinct AMD phenotypes seems to be influenced by different genetic factors [<xref ref-type="bibr" rid="r33">33</xref>-<xref ref-type="bibr" rid="r35">35</xref>], genetic association studies on AMD can be confounded by underlying sample heterogeneity. An example of this situation can be seen in previous studies on <italic>TLR3</italic> for its association with AMD. Edwards et al. [<xref ref-type="bibr" rid="r39">39</xref>] examined polymorphisms across <italic>TLR</italic> genes, including the <italic>TLR3</italic> Leu412Phe variant, in a mixed sample of early AMD, dry AMD, and neovascular AMD. This analysis was not restricted to dry AMD, and the authors failed to detect a phenotype-specific association of <italic>TLR3</italic> Leu412Phe with dry AMD. In contrast, Yang et al. [<xref ref-type="bibr" rid="r34">34</xref>] selectively studied subgroups of subjects with early AMD, dry AMD, and neovascular AMD and eventually found that the Leu412Phe variant specifically contributes to the risk of developing dry AMD. Similarly, the inconsistent finding of the <italic>PEDF</italic> Met72Thr variant could be due to potential sample heterogeneity between the studies by Lin et al. and Mattes et al. Therefore, this association needed to be examined in a case series of clearly defined individuals with neovascular AMD and PCV. The aim of this study was to validate the previously reported association of the <italic>PEDF</italic> Met72Thr variant in a well characterized Japanese population with neovascular AMD and PCV.</p></sec><sec sec-type="methods"><title>Methods</title><sec><title>Study participants</title><p>This study was approved by the Institutional Review Board at Kobe University Graduate School of Medicine and was conducted in accordance with the Declaration of Helsinki. Written informed consent was obtained from all participants. All case and control participants enrolled in this study (more information about participants in <xref ref-type="table" rid="t1">Table 1</xref>) were Japanese individuals recruited from the Department of Ophthalmology at Kobe University Hospital in Kobe, Japan. This is largely the same sample set used in our previous studies in which phenotyping criteria were fully described [<xref ref-type="bibr" rid="r31">31</xref>-<xref ref-type="bibr" rid="r33">33</xref>,<xref ref-type="bibr" rid="r40">40</xref>]. In brief, all our neovascular AMD and PCV subjects underwent comprehensive ophthalmic examinations, including ICG angiography, and were defined as individuals with angiographically well delineated lesions of CNV or PCV. Patients with secondary choroidal neovascular diseases such as degenerative myopia, idiopathic CNV, ocular trauma, angioid streaks, and presumed ocular histoplasmosis were excluded from the recruitment. The control participants, who were not related to the case participants, were defined as individuals without macular degeneration and changes such as drusen or pigment abnormalities, and thus, were categorized as having the clinical age-related maculopathy staging system stage 1 [<xref ref-type="bibr" rid="r41">41</xref>].</p><table-wrap id="t1" position="float"><label>Table 1</label><caption><title>Characteristics of the study population</title></caption><table frame="hsides" rules="groups"><col width="131" span="1"/><col width="110" span="1"/><col width="54" span="1"/><col width="60" span="1"/><thead><tr><th valign="top" align="left" scope="col" rowspan="1" colspan="1">&#x000a0;</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>Neovascular AMD</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>PCV</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>Controls</bold></th></tr></thead><tbody><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Number of participants<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">116<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">140<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">189<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Males (%)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">78<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">77<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">60<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Mean age&#x000b1;SD (years)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">75&#x000b1;7.2<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">73&#x000b1;6.9<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">72&#x000b1;5.8<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Age range (years)</td><td valign="top" align="center" rowspan="1" colspan="1">57&#x02013;91</td><td valign="top" align="center" rowspan="1" colspan="1">57&#x02013;86</td><td valign="top" align="center" rowspan="1" colspan="1">56&#x02013;95</td></tr></tbody></table><table-wrap-foot><p>A total of 116 patients with neovascular AMD, 140 patients with PCV, and 189 control participants were enrolled in the present study. The gender breakdown, mean age, and age range of each population are shown. Abbreviations: age-related macular degeneration (AMD); polypoidal choroidal vasculopathy (PCV); standard deviation (SD).</p></table-wrap-foot></table-wrap></sec><sec><title>Genotyping</title><p>Genomic DNA was extracted from peripheral blood immediately after it was drawn. We genotyped the Met72Thr variant (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1136287">rs1136287</ext-link>) using TaqMan<sup>&#x000ae;</sup> SNP Genotyping Assays (Assay ID: C___1841779_20; Applied Biosystems, Foster City, CA) on a StepOnePlus&#x02122; Real-Time PCR system (Applied Biosystems), in accordance with the manufacturer&#x02019;s instructions. For verification, a random 10% of samples were genotyped twice, yielding 100% concordance.</p></sec><sec><title>Statistical analysis</title><p>Testing for association was performed using software packages <ext-link ext-link-type="uri" xlink:href="http://www.phs.wfubmc.edu/public/bios/gene/downloads.cfm">SNPGWA</ext-link> v3.02. Deviations from Hardy&#x02013;Weinberg equilibrium (HWE) were evaluated using the exact test [<xref ref-type="bibr" rid="r42">42</xref>] implemented in <ext-link ext-link-type="uri" xlink:href="http://www.phs.wfubmc.edu/public/bios/gene/downloads.cfm">SNPGWA</ext-link>. We performed association analyses using the Cochran-Armitage trend test [<xref ref-type="bibr" rid="r43">43</xref>] and genotypic (2 degrees of freedom, &#x003c7;<sup>2</sup> test), dominant (1 degree of freedom, &#x003c7;<sup>2</sup> test), and recessive (1 degree of freedom, &#x003c7;<sup>2</sup> test) genetic models. The max(T) permutation procedure implemented in <ext-link ext-link-type="uri" xlink:href="http://pngu.mgh.harvard.edu/purcell/plink/">PLINK</ext-link> v1.00 was used with 10,000 iterations to obtain empirical p values [<xref ref-type="bibr" rid="r44">44</xref>]. To adjust for age and gender differences between case and control subjects, we conducted logistic regression analyses using JMP version 6.0.3 software (SAS Institute, Cary, NC), assuming a multiplicative codominant genetic model by fitting the number of minor allele carried as an ordinal covariate and age and gender as continuous and categorical covariates, respectively. Power calculations were performed using <ext-link ext-link-type="uri" xlink:href="http://hydra.usc.edu/gxe">QUANTO</ext-link> version 1.2 [<xref ref-type="bibr" rid="r45">45</xref>]. We had full power to detect the OR reported in the original studies for rs1136287 (OR=3.90 under a recessive genetic model) at p&#x0003c;0.05 for both neovascular AMD and PCV. Assuming an additive genetic model, we had 80% power to detect an association of this variant with ORs &#x02265;1.61 (or &#x02264;0.62) for the neovascular AMD sample and &#x02265;1.56 (or &#x02264;0.63) for the PCV sample.</p><p>Linkage disequilibrium (LD) structures across the <italic>PEDF</italic> gene were compared between Chinese and Japanese populations, using genotype data retrieved from the HapMap [<xref ref-type="bibr" rid="r46">46</xref>] CHB (Han Chinese in Beijing, China) and JPT (Japanese in Tokyo, Japan) data sets. These retrieved data were loaded into Haploview [<xref ref-type="bibr" rid="r47">47</xref>] to estimate LD parameters and identify haplotype blocks.</p><p>Hidden population stratification in genetic association studies can generate a spurious positive or negative association [<xref ref-type="bibr" rid="r48">48</xref>]. To prevent potential stratification in our study cohort, we evaluated population stratification using STRUCTURE software [<xref ref-type="bibr" rid="r49">49</xref>], as described in previous studies [<xref ref-type="bibr" rid="r40">40</xref>,<xref ref-type="bibr" rid="r50">50</xref>,<xref ref-type="bibr" rid="r51">51</xref>]. The following 38 single nucleotide polymorphisms (SNPs), which were randomly distributed along the genome and are not in LD with each other (r<sup>2</sup>&#x0003c;0.04), were used for stratification analysis: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3818729">rs3818729</ext-link> (1p13.2), <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=696619">rs696619</ext-link> (1p21.3), <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=9434">rs9434</ext-link> (1p36.12), <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1554286">rs1554286</ext-link> (1q32.1), <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=13388696">rs13388696</ext-link> (2p23.1), <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1042034">rs1042034</ext-link> (2p24.1), <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=10932613">rs10932613</ext-link> (2q35), <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=7641926">rs7641926</ext-link> (3p26.2), <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=2305619">rs2305619</ext-link> (3q25.32), <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=4074">rs4074</ext-link> (4q13.3), <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=6876885">rs6876885</ext-link> (5p15.1), <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=6459193">rs6459193</ext-link> (6p11.2), <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3779109">rs3779109</ext-link> (7p22.1), <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=2227667">rs2227667</ext-link> (7q22.1), <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=6468284">rs6468284</ext-link> (8p12), <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=10757278">rs10757278</ext-link> (9p21.3), <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=955220">rs955220</ext-link> (9p24.3), <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1927911">rs1927911</ext-link> (9q33.1), <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=4838590">rs4838590</ext-link> (10q11.22), <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=12806">rs12806</ext-link> (10q24.2), <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=2019938">rs2019938</ext-link> (11p15.5), <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=609017">rs609017</ext-link> (11q24.3), <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3912640">rs3912640</ext-link> (12p13.2), <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=2283299">rs2283299</ext-link> (12p13.33), <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=715948">rs715948</ext-link> (12q13.3), <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=7328193">rs7328193</ext-link> (13q12.11), <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048990">rs1048990</ext-link> (14q13.2), <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=911669">rs911669</ext-link> (14q32.13), <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=16948719">rs16948719</ext-link> (15q22.31), <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=11076720">rs11076720</ext-link> (16q24.3), <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1051009">rs1051009</ext-link> (17p13.2), <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1292033">rs1292033</ext-link> (17q23.1), <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=7239116">rs7239116</ext-link> (18q11.2), <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=892115">rs892115</ext-link> (19p13.2), <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3826945">rs3826945</ext-link> (19p13.3), <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=844906">rs844906</ext-link> (20p11.21), <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=2825761">rs2825761</ext-link> (21q21.1), and <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3884935">rs3884935</ext-link> (22q13.1). The log likelihood of each analysis at a varying number <italic>K</italic> (the number of populations) was computed from three independent runs (20,000 burn-in and 30,000 iterations). The best estimate of <italic>K</italic> was defined by calculating posterior probabilities <italic>Pr</italic> (<italic>K</italic>=1, 2, 3, 4, or 5) based on the log likelihood, as described by Pritchard et al. [<xref ref-type="bibr" rid="r52">52</xref>].</p></sec></sec><sec sec-type="results"><title>Results</title><p>A total of 116 patients with neovascular AMD, 140 patients with PCV, and 189 control participants participated in the study. <xref ref-type="table" rid="t1">Table 1</xref> shows the demographic details of the study population. The <italic>PEDF</italic> Met72Thr (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1136287">rs1136287</ext-link>) variant showed no significant deviation from Hardy&#x02013;Weinberg equilibrium in the control participants (p=0.66).</p><p>Details of allele and genotype counts and summary statistics for <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1136287">rs1136287</ext-link> are shown in <xref ref-type="table" rid="t2">Table 2</xref>. We found no statistically significant evidence for association between <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1136287">rs1136287</ext-link> and either neovascular AMD or PCV under any genetic models (<xref ref-type="table" rid="t2">Table 2</xref>). Adjusting for age and gender by logistic regression analyses did not affect the conclusion (age- and sex-adjusted p=0.59 for neovascular AMD; age- and sex-adjusted p=0.33 for PCV, under a multiplicative codominant model).</p><table-wrap id="t2" position="float"><label>Table 2</label><caption><title>Allele and genotype distributions of rs1136287 and the results of association tests</title></caption><table frame="hsides" rules="groups"><col width="89" span="1"/><col width="54" span="1"/><col width="60" span="1"/><col width="60" span="1"/><col width="66" span="1"/><col width="96" span="1"/><col width="66" span="1"/><col width="66" span="1"/><col width="66" span="1"/><col width="66" span="1"/><thead><tr><th rowspan="2" valign="top" align="left" scope="col" colspan="1"><bold>Status</bold></th><th colspan="3" valign="top" align="center" scope="colgroup" rowspan="1"><bold>Genotype</bold><hr/></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>Allele</bold><hr/></th><th rowspan="3" valign="top" align="center" scope="col" colspan="1"><bold>OR trend*</bold>&#x02028;<bold>(95% CI)</bold><hr/></th><th colspan="4" valign="top" align="center" scope="colgroup" rowspan="1"><bold>p values (empirical p values)</bold><hr/></th></tr><tr><th valign="top" colspan="1" align="center" scope="colgroup" rowspan="1"><bold>CC</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>CT</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>TT</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>T</bold></th><th valign="top" colspan="1" align="center" scope="colgroup" rowspan="1"><bold>Trend</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>Genotype</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>Dominant</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>Recessive</bold></th></tr></thead><tbody><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Control<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">56 (0.30)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">91 (0.48)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">42 (0.22)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">175 (0.46)<hr/></td><td valign="top" colspan="1" align="center" rowspan="1">-<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">-<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">-<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">-<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Neovascular AMD<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">41 (0.35)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">52 (0.45)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">23 (0.20)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">98 (0.42)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.86 (0.62&#x02013;1.18)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.34 (0.35)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.58 (0.58)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.30 (0.32)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.62 (0.67)<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">PCV</td><td valign="top" align="center" rowspan="1" colspan="1">32 (0.23)</td><td valign="top" align="center" rowspan="1" colspan="1">78 (0.56)</td><td valign="top" align="center" rowspan="1" colspan="1">30 (0.21)</td><td valign="top" align="center" rowspan="1" colspan="1">138 (0.49)</td><td valign="top" align="center" rowspan="1" colspan="1">1.13 (0.83&#x02013;1.55)</td><td valign="top" align="center" rowspan="1" colspan="1">0.44 (0.47)</td><td valign="top" align="center" rowspan="1" colspan="1">0.32 (0.31)</td><td valign="top" align="center" rowspan="1" colspan="1">0.17 (0.20)</td><td valign="top" align="center" rowspan="1" colspan="1">0.86 (0.89)</td></tr></tbody></table><table-wrap-foot><p>The trend p values were obtained by the Cochran-Armitage trend test. Genotypic p values were generated by chi-square tests on 2&#x000d7;3 contingency tables. Tests for the dominant and recessive models were set up as 2&#x000d7;2 contingency table chi-square tests. The dominant model compared a combination of C/T+T/T genotypes to the homozygous C/C. The recessive model compared a combination of C/C+C/T to the homozygous T/T. Empirical p values were generated by 10,000 permutation tests, using the max(T) permutation procedure implemented in PLINK [<xref ref-type="bibr" rid="r44">44</xref>]. Asterisk (*) indicates OR trend test. Abbreviations: odds ratio (OR); confidence interval (CI); age-related macular degeneration (AMD); polypoidal choroidal vasculopathy (PCV).</p></table-wrap-foot></table-wrap><p>We also explored the possibility that failure to replicate the previously reported association could arise due to differences in LD structure between Chinese and Japanese populations&#x02014;i.e., if the Met72Thr variant is only a proxy for some other true causative variant, the inconsistency may be due to a difference in LD for a pair of the Met72Thr and causal variants between Chinese and Japanese populations. To this end, we compared LD structures across the <italic>PEDF</italic> gene between Chinese and Japanese populations, using genotype data retrieved from the HapMap [<xref ref-type="bibr" rid="r46">46</xref>] CHB and JPT data set. This analysis revealed that the HapMap Chinese (CHB) and Japanese (JPT) populations are highly similar with regard to LD pattern and structure of LD blocks across the <italic>PEDF</italic> gene (<xref ref-type="fig" rid="f1">Figure 1</xref>).</p><fig id="f1" fig-type="figure" position="float"><label>Figure 1</label><caption><p>Linkage disequilibrium structure across the pigment epithelium-derived factor gene in Chinese and Japanese populations. Genotype data were retrieved from HapMap CHB (Han Chinese in Beijing, China; <bold>A</bold>) and JPT (Japanese in Tokyo, Japan; <bold>B</bold>) data sets, and linkage disequilibrium (LD) patterns were assessed using Haploview software [<xref ref-type="bibr" rid="r47">47</xref>]. Haplotype blocks were determined using the &#x0201c;four-gamete rule&#x0201d; option in this software. Each box provides estimated statistics of the coefficient of determination (r<sup>2</sup>), with darker shades representing stronger LD.</p></caption><graphic xlink:href="mv-v15-1107-f1"/></fig><p>Next, we examined SNPs within <italic>PEDF</italic> in an available data set, the <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?id=phs000001">NEI/NCBI dbGAP</ext-link> database. This database provides results of genome-wide association analysis for 395 individuals with AMD and 198 controls from the National Eye Institute Age-Related Eye Disease Study (AREDS). This genome-wide association study investigated seven <italic>PEDF</italic> SNPs, including the SNP <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1136287">rs1136287</ext-link> (Met72Thr) tested here and six other SNPs (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=8074840">rs8074840</ext-link>, <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=4274474">rs4274474</ext-link>, <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=2269344">rs2269344</ext-link>, <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3891224">rs3891224</ext-link>, <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=2071021">rs2071021</ext-link>, and <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=6828">rs6828</ext-link>). None of these seven SNPs showed significant association with AMD in this analysis (p&#x0003e;0.05).</p><p>Hidden population stratification between case and control subjects can be a confounding factor yielding false-positive or false-negative findings [<xref ref-type="bibr" rid="r48">48</xref>]. Population stratification was examined by STRUCTURE [<xref ref-type="bibr" rid="r49">49</xref>], using 38 unlinked genome-wide SNPs. We found no evidence of stratification in our study cohort, using the formula;</p><disp-formula><mml:math id="e"><mml:mrow><mml:mi>P</mml:mi><mml:mi>r</mml:mi><mml:mtext>&#x000a0;</mml:mtext><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi>K</mml:mi><mml:mo>=</mml:mo><mml:mtext>1&#x000a0;</mml:mtext><mml:mo>&#x0003e;</mml:mo><mml:mtext>&#x000a0;</mml:mtext><mml:mn>0.</mml:mn><mml:mtext>99</mml:mtext></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>,</mml:mo></mml:mrow></mml:math></disp-formula><p>thus indicating that our results did not arise from population stratification.</p></sec><sec sec-type="discussion"><title>Discussion</title><p>To validate the recently reported association between the <italic>PEDF</italic> Met72Thr variant and wet AMD in a Taiwan Chinese population [<xref ref-type="bibr" rid="r36">36</xref>], we analyzed this variant in Japanese subjects with neovascular AMD and PCV separately, given the possibility that a case population of the original report might be a mixed sample of neovascular AMD and PCV. Despite sufficient power to replicate the originally reported association, we found no statistically significant evidence for association between this variant and either neovascular AMD or PCV.</p><p>PEDF is mainly a secreted 50&#x000a0;kDa glycoprotein that is found in various ocular tissues including retinal pigment epithelium and choroid [<xref ref-type="bibr" rid="r53">53</xref>,<xref ref-type="bibr" rid="r54">54</xref>]. PEDF potently inhibits angiogenesis and plays a pivotal role in maintaining vascular quiescence in the eye [<xref ref-type="bibr" rid="r54">54</xref>,<xref ref-type="bibr" rid="r55">55</xref>]. Specifically, PEDF has been repeatedly implicated in the pathology of neovascular AMD: CNV is associated with decreased levels of PEDF in an eye with neovascular AMD [<xref ref-type="bibr" rid="r56">56</xref>,<xref ref-type="bibr" rid="r57">57</xref>], <italic>PEDF</italic> gene transfer in the eye inhibits laser-induced CNV growth and promotes regression of established CNV in a murine model [<xref ref-type="bibr" rid="r58">58</xref>,<xref ref-type="bibr" rid="r59">59</xref>], and adenoviral vector-mediated intravitreal gene transfer of PEDF seems to help prevent the growth of CNV in patients with neovascular AMD [<xref ref-type="bibr" rid="r60">60</xref>]. Thus, from a functional perspective, <italic>PEDF</italic> appeared to be a reasonable candidate for genetic susceptibility to neovascular AMD.</p><p>Disease heterogeneity can result in false-positive reporting or can obscure the existence of true associations. Population stratification can also generate inconsistent findings across studies, thus yielding false-positive or false-negative association. To address these concerns, we performed association analysis for both neovascular AMD and PCV because of the unclear definition of the disease phenotype included in the original study [<xref ref-type="bibr" rid="r36">36</xref>]. We also examined population stratification in our study cohort and confirmed the lack of stratification. Many other reasons for irreproducibility of initial positive findings have been cited, with failure to exclude chance being considered the most likely explanation for difficulty in replication [<xref ref-type="bibr" rid="r61">61</xref>,<xref ref-type="bibr" rid="r62">62</xref>]. To protect against a range of confounding factors and to provide greater support for a claim of association, initial positive studies should preferably include multiple replication samples [<xref ref-type="bibr" rid="r61">61</xref>,<xref ref-type="bibr" rid="r62">62</xref>]. However, Lin et al. did not validate their finding in a second sample, nor did they evaluate potential stratification in their study cohort [<xref ref-type="bibr" rid="r36">36</xref>]. Finally, our inability to replicate the previously reported association may result from differences in the structure of LD across the <italic>PEDF</italic> gene region between Chinese and Japanese populations. However, examination of HapMap data [<xref ref-type="bibr" rid="r46">46</xref>] revealed that the HapMap Chinese and Japanese populations are similar in LD pattern and structure of LD blocks across the <italic>PEDF</italic> gene (<xref ref-type="fig" rid="f1">Figure 1</xref>). Mattes et al. also [<xref ref-type="bibr" rid="r38">38</xref>] failed to replicate the original finding of Lin et al. [<xref ref-type="bibr" rid="r36">36</xref>]. Additional support of our negative findings comes from the genome-wide association study on the <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?id=phs000001">AREDS cohort</ext-link>. Our experience highlights the importance of replication efforts in genetic association studies of complex human diseases.</p><p>In conclusion, we report a lack of association between the <italic>PEDF</italic> Met72Thr variant and either neovascular AMD or PCV in a Japanese population. We conclude that the Met72Thr variant does not play a significant role in the risk of developing neovascular AMD or PCV.</p></sec></body><back><ack><title>Acknowledgments</title><p>This study was supported by a grant-in-aid (C) 17591836 from the Ministry of Education, Science, and Culture, Tokyo, Japan. None of the authors have any financial or conflicting interests to disclose.</p></ack><ref-list><title>References</title><ref id="r1"><label>1</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Friedman</surname><given-names>DS</given-names></name><name><surname>O'Colmain</surname><given-names>BJ</given-names></name><name><surname>Munoz</surname><given-names>B</given-names></name><name><surname>Tomany</surname><given-names>SC</given-names></name><name><surname>McCarty</surname><given-names>C</given-names></name><name><surname>de Jong</surname><given-names>PT</given-names></name><name><surname>Nemesure</surname><given-names>B</given-names></name><name><surname>Mitchell</surname><given-names>P</given-names></name><name><surname>Kempen</surname><given-names>J</given-names></name><collab>Eye Diseases Prevalence Research Group.</collab></person-group><article-title>Prevalence of age-related macular degeneration in the United States.</article-title><source>Arch Ophthalmol</source><year>2004</year><volume>122</volume><fpage>564</fpage><lpage>72</lpage><pub-id pub-id-type="pmid">15078675</pub-id></citation></ref><ref id="r2"><label>2</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jager</surname><given-names>RD</given-names></name><name><surname>Mieler</surname><given-names>WF</given-names></name><name><surname>Miller</surname><given-names>JW</given-names></name></person-group><article-title>Age-related macular degeneration.</article-title><source>N Engl J Med</source><year>2008</year><volume>358</volume><fpage>2606</fpage><lpage>17</lpage><pub-id pub-id-type="pmid">18550876</pub-id></citation></ref><ref id="r3"><label>3</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ciardella</surname><given-names>AP</given-names></name><name><surname>Donsoff</surname><given-names>IM</given-names></name><name><surname>Huang</surname><given-names>SJ</given-names></name><name><surname>Costa</surname><given-names>DL</given-names></name><name><surname>Yannuzzi</surname><given-names>LA</given-names></name></person-group><article-title>Polypoidal choroidal vasculopathy.</article-title><source>Surv Ophthalmol</source><year>2004</year><volume>49</volume><fpage>25</fpage><lpage>37</lpage><pub-id pub-id-type="pmid">14711438</pub-id></citation></ref><ref id="r4"><label>4</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yannuzzi</surname><given-names>LA</given-names></name><name><surname>Sorenson</surname><given-names>J</given-names></name><name><surname>Spaide</surname><given-names>RF</given-names></name><name><surname>Lipson</surname><given-names>B</given-names></name></person-group><article-title>Idiopathic polypoidal choroidal vasculopathy (IPCV).</article-title><source>Retina</source><year>1990</year><volume>10</volume><fpage>1</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">1693009</pub-id></citation></ref><ref id="r5"><label>5</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yannuzzi</surname><given-names>LA</given-names></name><name><surname>Wong</surname><given-names>DW</given-names></name><name><surname>Sforzolini</surname><given-names>BS</given-names></name><name><surname>Goldbaum</surname><given-names>M</given-names></name><name><surname>Tang</surname><given-names>KC</given-names></name><name><surname>Spaide</surname><given-names>RF</given-names></name><name><surname>Freund</surname><given-names>KB</given-names></name><name><surname>Slakter</surname><given-names>JS</given-names></name><name><surname>Guyer</surname><given-names>DR</given-names></name><name><surname>Sorenson</surname><given-names>JA</given-names></name><name><surname>Fisher</surname><given-names>Y</given-names></name><name><surname>Maberley</surname><given-names>D</given-names></name><name><surname>Orlock</surname><given-names>DA</given-names></name></person-group><article-title>Polypoidal choroidal vasculopathy and neovascularized age-related macular degeneration.</article-title><source>Arch Ophthalmol</source><year>1999</year><volume>117</volume><fpage>1503</fpage><lpage>10</lpage><pub-id pub-id-type="pmid">10565519</pub-id></citation></ref><ref id="r6"><label>6</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Takahashi</surname><given-names>K</given-names></name><name><surname>Ishibashi</surname><given-names>T</given-names></name><name><surname>Ogur</surname><given-names>Y</given-names></name><name><surname>Yuzawa</surname><given-names>M</given-names></name></person-group><article-title>Working Group for Establishing Diagnostic Criteria for Age-Related Macular Degeneration. Classification and diagnostic criteria of age-related macular degeneration.</article-title><source>Nippon Ganka Gakkai Zasshi</source><year>2008</year><volume>112</volume><fpage>1076</fpage><lpage>84</lpage><pub-id pub-id-type="pmid">19157028</pub-id></citation></ref><ref id="r7"><label>7</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Maruko</surname><given-names>I</given-names></name><name><surname>Iida</surname><given-names>T</given-names></name><name><surname>Saito</surname><given-names>M</given-names></name><name><surname>Nagayama</surname><given-names>D</given-names></name><name><surname>Saito</surname><given-names>K</given-names></name></person-group><article-title>Clinical characteristics of exudative age-related macular degeneration in Japanese patients.</article-title><source>Am J Ophthalmol</source><year>2007</year><volume>144</volume><fpage>15</fpage><lpage>22</lpage><pub-id pub-id-type="pmid">17509509</pub-id></citation></ref><ref id="r8"><label>8</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kikuchi</surname><given-names>M</given-names></name><name><surname>Nakamura</surname><given-names>M</given-names></name><name><surname>Ishikawa</surname><given-names>K</given-names></name><name><surname>Suzuki</surname><given-names>T</given-names></name><name><surname>Nishihara</surname><given-names>H</given-names></name><name><surname>Yamakoshi</surname><given-names>T</given-names></name><name><surname>Nishio</surname><given-names>K</given-names></name><name><surname>Taki</surname><given-names>K</given-names></name><name><surname>Niwa</surname><given-names>T</given-names></name><name><surname>Hamajima</surname><given-names>N</given-names></name><name><surname>Terasaki</surname><given-names>H</given-names></name></person-group><article-title>Elevated C-reactive protein levels in patients with polypoidal choroidal vasculopathy and patients with neovascular age-related macular degeneration.</article-title><source>Ophthalmology</source><year>2007</year><volume>114</volume><fpage>1722</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">17400294</pub-id></citation></ref><ref id="r9"><label>9</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Terasaki</surname><given-names>H</given-names></name><name><surname>Miyake</surname><given-names>Y</given-names></name><name><surname>Suzuki</surname><given-names>T</given-names></name><name><surname>Nakamura</surname><given-names>M</given-names></name><name><surname>Nagasaka</surname><given-names>T</given-names></name></person-group><article-title>Polypoidal choroidal vasculopathy treated with macular translocation: clinical pathological correlation.</article-title><source>Br J Ophthalmol</source><year>2002</year><volume>86</volume><fpage>321</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">11864892</pub-id></citation></ref><ref id="r10"><label>10</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tong</surname><given-names>JP</given-names></name><name><surname>Chan</surname><given-names>WM</given-names></name><name><surname>Liu</surname><given-names>DT</given-names></name><name><surname>Lai</surname><given-names>TY</given-names></name><name><surname>Choy</surname><given-names>KW</given-names></name><name><surname>Pang</surname><given-names>CP</given-names></name><name><surname>Lam</surname><given-names>DS</given-names></name></person-group><article-title>Aqueous humor levels of vascular endothelial growth factor and pigment epithelium-derived factor in polypoidal choroidal vasculopathy and choroidal neovascularization.</article-title><source>Am J Ophthalmol</source><year>2006</year><volume>141</volume><fpage>456</fpage><lpage>62</lpage><pub-id pub-id-type="pmid">16490490</pub-id></citation></ref><ref id="r11"><label>11</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nakajima</surname><given-names>M</given-names></name><name><surname>Yuzawa</surname><given-names>M</given-names></name><name><surname>Shimada</surname><given-names>H</given-names></name><name><surname>Mori</surname><given-names>R</given-names></name></person-group><article-title>Correlation between indocyanine green angiographic findings and histopathology of polypoidal choroidal vasculopathy.</article-title><source>Jpn J Ophthalmol</source><year>2004</year><volume>48</volume><fpage>249</fpage><lpage>55</lpage><pub-id pub-id-type="pmid">15175917</pub-id></citation></ref><ref id="r12"><label>12</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nakashizuka</surname><given-names>H</given-names></name><name><surname>Mitsumata</surname><given-names>M</given-names></name><name><surname>Okisaka</surname><given-names>S</given-names></name><name><surname>Shimada</surname><given-names>H</given-names></name><name><surname>Kawamura</surname><given-names>A</given-names></name><name><surname>Mori</surname><given-names>R</given-names></name><name><surname>Yuzawa</surname><given-names>M</given-names></name></person-group><article-title>Clinicopathologic findings in polypoidal choroidal vasculopathy.</article-title><source>Invest Ophthalmol Vis Sci</source><year>2008</year><volume>49</volume><fpage>4729</fpage><lpage>37</lpage><pub-id pub-id-type="pmid">18586873</pub-id></citation></ref><ref id="r13"><label>13</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gomi</surname><given-names>F</given-names></name><name><surname>Sawa</surname><given-names>M</given-names></name><name><surname>Sakaguchi</surname><given-names>H</given-names></name><name><surname>Tsujikawa</surname><given-names>M</given-names></name><name><surname>Oshima</surname><given-names>Y</given-names></name><name><surname>Kamei</surname><given-names>M</given-names></name><name><surname>Tano</surname><given-names>Y</given-names></name></person-group><article-title>Efficacy of intravitreal bevacizumab for polypoidal choroidal vasculopathy.</article-title><source>Br J Ophthalmol</source><year>2008</year><volume>92</volume><fpage>70</fpage><lpage>3</lpage><pub-id pub-id-type="pmid">17567661</pub-id></citation></ref><ref id="r14"><label>14</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Silva</surname><given-names>RM</given-names></name><name><surname>Figueira</surname><given-names>J</given-names></name><name><surname>Cachulo</surname><given-names>ML</given-names></name><name><surname>Duarte</surname><given-names>L</given-names></name><name><surname>Faria de Abreu</surname><given-names>JR</given-names></name><name><surname>Cunha-Vaz</surname><given-names>JG</given-names></name></person-group><article-title>Polypoidal choroidal vasculopathy and photodynamic therapy with verteporfin.</article-title><source>Graefes Arch Clin Exp Ophthalmol</source><year>2005</year><volume>243</volume><fpage>973</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">15864616</pub-id></citation></ref><ref id="r15"><label>15</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yuzawa</surname><given-names>M</given-names></name><name><surname>Mori</surname><given-names>R</given-names></name><name><surname>Kawamura</surname><given-names>A</given-names></name></person-group><article-title>The origins of polypoidal choroidal vasculopathy.</article-title><source>Br J Ophthalmol</source><year>2005</year><volume>89</volume><fpage>602</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">15834093</pub-id></citation></ref><ref id="r16"><label>16</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Wen</surname><given-names>F</given-names></name><name><surname>Huang</surname><given-names>S</given-names></name><name><surname>Luo</surname><given-names>G</given-names></name><name><surname>Yan</surname><given-names>H</given-names></name><name><surname>Sun</surname><given-names>Z</given-names></name><name><surname>Wu</surname><given-names>D</given-names></name></person-group><article-title>Subtype lesions of neovascular age-related macular degeneration in Chinese patients.</article-title><source>Graefes Arch Clin Exp Ophthalmol</source><year>2007</year><volume>245</volume><fpage>1441</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">17406882</pub-id></citation></ref><ref id="r17"><label>17</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Klein</surname><given-names>R</given-names></name><name><surname>Klein</surname><given-names>BE</given-names></name><name><surname>Linton</surname><given-names>KL</given-names></name></person-group><article-title>Prevalence of age-related maculopathy. The Beaver Dam Eye Study.</article-title><source>Ophthalmology</source><year>1992</year><volume>99</volume><fpage>933</fpage><lpage>43</lpage><pub-id pub-id-type="pmid">1630784</pub-id></citation></ref><ref id="r18"><label>18</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mitchell</surname><given-names>P</given-names></name><name><surname>Smith</surname><given-names>W</given-names></name><name><surname>Attebo</surname><given-names>K</given-names></name><name><surname>Wang</surname><given-names>JJ</given-names></name></person-group><article-title>Prevalence of age-related maculopathy in Australia. The Blue Mountains Eye Study.</article-title><source>Ophthalmology</source><year>1995</year><volume>102</volume><fpage>1450</fpage><lpage>60</lpage><pub-id pub-id-type="pmid">9097791</pub-id></citation></ref><ref id="r19"><label>19</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Oshima</surname><given-names>Y</given-names></name><name><surname>Ishibashi</surname><given-names>T</given-names></name><name><surname>Murata</surname><given-names>T</given-names></name><name><surname>Tahara</surname><given-names>Y</given-names></name><name><surname>Kiyohara</surname><given-names>Y</given-names></name><name><surname>Kubota</surname><given-names>T</given-names></name></person-group><article-title>Prevalence of age related maculopathy in a representative Japanese population: the Hisayama study.</article-title><source>Br J Ophthalmol</source><year>2001</year><volume>85</volume><fpage>1153</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">11567955</pub-id></citation></ref><ref id="r20"><label>20</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Haddad</surname><given-names>S</given-names></name><name><surname>Chen</surname><given-names>CA</given-names></name><name><surname>Santangelo</surname><given-names>SL</given-names></name><name><surname>Seddon</surname><given-names>JM</given-names></name></person-group><article-title>The genetics of age-related macular degeneration: a review of progress to date.</article-title><source>Surv Ophthalmol</source><year>2006</year><volume>51</volume><fpage>316</fpage><lpage>63</lpage><pub-id pub-id-type="pmid">16818082</pub-id></citation></ref><ref id="r21"><label>21</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Scholl</surname><given-names>HP</given-names></name><name><surname>Fleckenstein</surname><given-names>M</given-names></name><name><surname>Charbel Issa</surname><given-names>P</given-names></name><name><surname>Keilhauer</surname><given-names>C</given-names></name><name><surname>Holz</surname><given-names>FG</given-names></name><name><surname>Weber</surname><given-names>BH</given-names></name></person-group><article-title>An update on the genetics of age-related macular degeneration.</article-title><source>Mol Vis</source><year>2007</year><volume>13</volume><fpage>196</fpage><lpage>205</lpage><pub-id pub-id-type="pmid">17327825</pub-id></citation></ref><ref id="r22"><label>22</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Edwards</surname><given-names>AO</given-names></name><name><surname>Ritter</surname><given-names>R</given-names><suffix>3rd</suffix></name><name><surname>Abel</surname><given-names>KJ</given-names></name><name><surname>Manning</surname><given-names>A</given-names></name><name><surname>Panhuysen</surname><given-names>C</given-names></name><name><surname>Farrer</surname><given-names>LA</given-names></name></person-group><article-title>Complement factor H polymorphism and age-related macular degeneration.</article-title><source>Science</source><year>2005</year><volume>308</volume><fpage>421</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">15761121</pub-id></citation></ref><ref id="r23"><label>23</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Haines</surname><given-names>JL</given-names></name><name><surname>Hauser</surname><given-names>MA</given-names></name><name><surname>Schmidt</surname><given-names>S</given-names></name><name><surname>Scott</surname><given-names>WK</given-names></name><name><surname>Olson</surname><given-names>LM</given-names></name><name><surname>Gallins</surname><given-names>P</given-names></name><name><surname>Spencer</surname><given-names>KL</given-names></name><name><surname>Kwan</surname><given-names>SY</given-names></name><name><surname>Noureddine</surname><given-names>M</given-names></name><name><surname>Gilbert</surname><given-names>JR</given-names></name><name><surname>Schnetz-Boutaud</surname><given-names>N</given-names></name><name><surname>Agarwal</surname><given-names>A</given-names></name><name><surname>Postel</surname><given-names>EA</given-names></name><name><surname>Pericak-Vance</surname><given-names>MA</given-names></name></person-group><article-title>Complement factor H variant increases the risk of age-related macular degeneration.</article-title><source>Science</source><year>2005</year><volume>308</volume><fpage>419</fpage><lpage>21</lpage><pub-id pub-id-type="pmid">15761120</pub-id></citation></ref><ref id="r24"><label>24</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Klein</surname><given-names>RJ</given-names></name><name><surname>Zeiss</surname><given-names>C</given-names></name><name><surname>Chew</surname><given-names>EY</given-names></name><name><surname>Tsai</surname><given-names>JY</given-names></name><name><surname>Sackler</surname><given-names>RS</given-names></name><name><surname>Haynes</surname><given-names>C</given-names></name><name><surname>Henning</surname><given-names>AK</given-names></name><name><surname>SanGiovanni</surname><given-names>JP</given-names></name><name><surname>Mane</surname><given-names>SM</given-names></name><name><surname>Mayne</surname><given-names>ST</given-names></name><name><surname>Bracken</surname><given-names>MB</given-names></name><name><surname>Ferris</surname><given-names>FL</given-names></name><name><surname>Ott</surname><given-names>J</given-names></name><name><surname>Barnstable</surname><given-names>C</given-names></name><name><surname>Hoh</surname><given-names>J</given-names></name></person-group><article-title>Complement factor H polymorphism in age-related macular degeneration.</article-title><source>Science</source><year>2005</year><volume>308</volume><fpage>385</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">15761122</pub-id></citation></ref><ref id="r25"><label>25</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Magnusson</surname><given-names>KP</given-names></name><name><surname>Duan</surname><given-names>S</given-names></name><name><surname>Sigurdsson</surname><given-names>H</given-names></name><name><surname>Petursson</surname><given-names>H</given-names></name><name><surname>Yang</surname><given-names>Z</given-names></name><name><surname>Zhao</surname><given-names>Y</given-names></name><name><surname>Bernstein</surname><given-names>PS</given-names></name><name><surname>Ge</surname><given-names>J</given-names></name><name><surname>Jonasson</surname><given-names>F</given-names></name><name><surname>Stefansson</surname><given-names>E</given-names></name><name><surname>Helgadottir</surname><given-names>G</given-names></name><name><surname>Zabriskie</surname><given-names>NA</given-names></name><name><surname>Jonsson</surname><given-names>T</given-names></name><name><surname>Bj&#x000f6;rnsson</surname><given-names>A</given-names></name><name><surname>Thorlacius</surname><given-names>T</given-names></name><name><surname>Jonsson</surname><given-names>PV</given-names></name><name><surname>Thorleifsson</surname><given-names>G</given-names></name><name><surname>Kong</surname><given-names>A</given-names></name><name><surname>Stefansson</surname><given-names>H</given-names></name><name><surname>Zhang</surname><given-names>K</given-names></name><name><surname>Stefansson</surname><given-names>K</given-names></name><name><surname>Gulcher</surname><given-names>JR</given-names></name></person-group><article-title>CFH Y402H confers similar risk of soft drusen and both forms of advanced AMD.</article-title><source>PLoS Med</source><year>2006</year><volume>3</volume><fpage>e5</fpage><pub-id pub-id-type="pmid">16300415</pub-id></citation></ref><ref id="r26"><label>26</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Maller</surname><given-names>J</given-names></name><name><surname>George</surname><given-names>S</given-names></name><name><surname>Purcell</surname><given-names>S</given-names></name><name><surname>Fagerness</surname><given-names>J</given-names></name><name><surname>Altshuler</surname><given-names>D</given-names></name><name><surname>Daly</surname><given-names>MJ</given-names></name><name><surname>Seddon</surname><given-names>JM</given-names></name></person-group><article-title>Common variation in three genes, including a noncoding variant in CFH, strongly influences risk of age-related macular degeneration.</article-title><source>Nat Genet</source><year>2006</year><volume>38</volume><fpage>1055</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">16936732</pub-id></citation></ref><ref id="r27"><label>27</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cameron</surname><given-names>DJ</given-names></name><name><surname>Yang</surname><given-names>Z</given-names></name><name><surname>Gibbs</surname><given-names>D</given-names></name><name><surname>Chen</surname><given-names>H</given-names></name><name><surname>Kaminoh</surname><given-names>Y</given-names></name><name><surname>Jorgensen</surname><given-names>A</given-names></name><name><surname>Zeng</surname><given-names>J</given-names></name><name><surname>Luo</surname><given-names>L</given-names></name><name><surname>Brinton</surname><given-names>E</given-names></name><name><surname>Brinton</surname><given-names>G</given-names></name><name><surname>Brand</surname><given-names>JM</given-names></name><name><surname>Bernstein</surname><given-names>PS</given-names></name><name><surname>Zabriskie</surname><given-names>NA</given-names></name><name><surname>Tang</surname><given-names>S</given-names></name><name><surname>Constantine</surname><given-names>R</given-names></name><name><surname>Tong</surname><given-names>Z</given-names></name><name><surname>Zhang</surname><given-names>K</given-names></name></person-group><article-title>HTRA1 variant confers similar risks to geographic atrophy and neovascular age-related macular degeneration.</article-title><source>Cell Cycle</source><year>2007</year><volume>6</volume><fpage>1122</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">17426452</pub-id></citation></ref><ref id="r28"><label>28</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fritsche</surname><given-names>LG</given-names></name><name><surname>Loenhardt</surname><given-names>T</given-names></name><name><surname>Janssen</surname><given-names>A</given-names></name><name><surname>Fisher</surname><given-names>SA</given-names></name><name><surname>Rivera</surname><given-names>A</given-names></name><name><surname>Keilhauer</surname><given-names>CN</given-names></name><name><surname>Weber</surname><given-names>BH</given-names></name></person-group><article-title>Age-related macular degeneration is associated with an unstable ARMS2 (LOC387715) mRNA.</article-title><source>Nat Genet</source><year>2008</year><volume>40</volume><fpage>892</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">18511946</pub-id></citation></ref><ref id="r29"><label>29</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dewan</surname><given-names>A</given-names></name><name><surname>Liu</surname><given-names>M</given-names></name><name><surname>Hartman</surname><given-names>S</given-names></name><name><surname>Zhang</surname><given-names>SS</given-names></name><name><surname>Liu</surname><given-names>DT</given-names></name><name><surname>Zhao</surname><given-names>C</given-names></name><name><surname>Tam</surname><given-names>PO</given-names></name><name><surname>Chan</surname><given-names>WM</given-names></name><name><surname>Lam</surname><given-names>DS</given-names></name><name><surname>Snyder</surname><given-names>M</given-names></name><name><surname>Barnstable</surname><given-names>C</given-names></name><name><surname>Pang</surname><given-names>CP</given-names></name><name><surname>Hoh</surname><given-names>J</given-names></name></person-group><article-title>HTRA1 promoter polymorphism in wet age-related macular degeneration.</article-title><source>Science</source><year>2006</year><volume>314</volume><fpage>989</fpage><lpage>92</lpage><pub-id pub-id-type="pmid">17053108</pub-id></citation></ref><ref id="r30"><label>30</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>Z</given-names></name><name><surname>Camp</surname><given-names>NJ</given-names></name><name><surname>Sun</surname><given-names>H</given-names></name><name><surname>Tong</surname><given-names>Z</given-names></name><name><surname>Gibbs</surname><given-names>D</given-names></name><name><surname>Cameron</surname><given-names>DJ</given-names></name><name><surname>Chen</surname><given-names>H</given-names></name><name><surname>Zhao</surname><given-names>Y</given-names></name><name><surname>Pearson</surname><given-names>E</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Chien</surname><given-names>J</given-names></name><name><surname>Dewan</surname><given-names>A</given-names></name><name><surname>Harmon</surname><given-names>J</given-names></name><name><surname>Bernstein</surname><given-names>PS</given-names></name><name><surname>Shridhar</surname><given-names>V</given-names></name><name><surname>Zabriskie</surname><given-names>NA</given-names></name><name><surname>Hoh</surname><given-names>J</given-names></name><name><surname>Howes</surname><given-names>K</given-names></name><name><surname>Zhang</surname><given-names>K</given-names></name></person-group><article-title>A variant of the HTRA1 gene increases susceptibility to age-related macular degeneration.</article-title><source>Science</source><year>2006</year><volume>314</volume><fpage>992</fpage><lpage>3</lpage><pub-id pub-id-type="pmid">17053109</pub-id></citation></ref><ref id="r31"><label>31</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kondo</surname><given-names>N</given-names></name><name><surname>Honda</surname><given-names>S</given-names></name><name><surname>Ishibashi</surname><given-names>K</given-names></name><name><surname>Tsukahara</surname><given-names>Y</given-names></name><name><surname>Negi</surname><given-names>A</given-names></name></person-group><article-title>LOC387715/HTRA1 variants in polypoidal choroidal vasculopathy and age-related macular degeneration in a Japanese population.</article-title><source>Am J Ophthalmol</source><year>2007</year><volume>144</volume><fpage>608</fpage><lpage>12</lpage><pub-id pub-id-type="pmid">17692272</pub-id></citation></ref><ref id="r32"><label>32</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kondo</surname><given-names>N</given-names></name><name><surname>Honda</surname><given-names>S</given-names></name><name><surname>Kuno</surname><given-names>S</given-names></name><name><surname>Negi</surname><given-names>A</given-names></name></person-group><article-title>Coding variant I62V in the complement factor H gene is strongly associated with polypoidal choroidal vasculopathy.</article-title><source>Ophthalmology</source><year>2009</year><volume>116</volume><fpage>304</fpage><lpage>10</lpage><pub-id pub-id-type="pmid">19187823</pub-id></citation></ref><ref id="r33"><label>33</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kondo</surname><given-names>N</given-names></name><name><surname>Honda</surname><given-names>S</given-names></name><name><surname>Ishibashi</surname><given-names>K</given-names></name><name><surname>Tsukahara</surname><given-names>Y</given-names></name><name><surname>Negi</surname><given-names>A</given-names></name></person-group><article-title>Elastin gene polymorphisms in neovascular age-related macular degeneration and polypoidal choroidal vasculopathy.</article-title><source>Invest Ophthalmol Vis Sci</source><year>2008</year><volume>49</volume><fpage>1101</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">18326737</pub-id></citation></ref><ref id="r34"><label>34</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>Z</given-names></name><name><surname>Stratton</surname><given-names>C</given-names></name><name><surname>Francis</surname><given-names>PJ</given-names></name><name><surname>Kleinman</surname><given-names>ME</given-names></name><name><surname>Tan</surname><given-names>PL</given-names></name><name><surname>Gibbs</surname><given-names>D</given-names></name><name><surname>Tong</surname><given-names>Z</given-names></name><name><surname>Chen</surname><given-names>H</given-names></name><name><surname>Constantine</surname><given-names>R</given-names></name><name><surname>Yang</surname><given-names>X</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Zeng</surname><given-names>J</given-names></name><name><surname>Davey</surname><given-names>L</given-names></name><name><surname>Ma</surname><given-names>X</given-names></name><name><surname>Hau</surname><given-names>VS</given-names></name><name><surname>Wang</surname><given-names>C</given-names></name><name><surname>Harmon</surname><given-names>J</given-names></name><name><surname>Buehler</surname><given-names>J</given-names></name><name><surname>Pearson</surname><given-names>E</given-names></name><name><surname>Patel</surname><given-names>S</given-names></name><name><surname>Kaminoh</surname><given-names>Y</given-names></name><name><surname>Watkins</surname><given-names>S</given-names></name><name><surname>Luo</surname><given-names>L</given-names></name><name><surname>Zabriskie</surname><given-names>NA</given-names></name><name><surname>Bernstein</surname><given-names>PS</given-names></name><name><surname>Cho</surname><given-names>W</given-names></name><name><surname>Schwager</surname><given-names>A</given-names></name><name><surname>Hinton</surname><given-names>DR</given-names></name><name><surname>Klein</surname><given-names>ML</given-names></name><name><surname>Hamon</surname><given-names>SC</given-names></name><name><surname>Simmons</surname><given-names>E</given-names></name><name><surname>Yu</surname><given-names>B</given-names></name><name><surname>Campochiaro</surname><given-names>B</given-names></name><name><surname>Sunness</surname><given-names>JS</given-names></name><name><surname>Campochiaro</surname><given-names>P</given-names></name><name><surname>Jorde</surname><given-names>L</given-names></name><name><surname>Parmigiani</surname><given-names>G</given-names></name><name><surname>Zack</surname><given-names>DJ</given-names></name><name><surname>Katsanis</surname><given-names>N</given-names></name><name><surname>Ambati</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>K</given-names></name></person-group><article-title>Toll-like receptor 3 and geographic atrophy in age-related macular degeneration.</article-title><source>N Engl J Med</source><year>2008</year><volume>359</volume><fpage>1456</fpage><lpage>63</lpage><pub-id pub-id-type="pmid">18753640</pub-id></citation></ref><ref id="r35"><label>35</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Swaroop</surname><given-names>A</given-names></name><name><surname>Branham</surname><given-names>KE</given-names></name><name><surname>Chen</surname><given-names>W</given-names></name><name><surname>Abecasis</surname><given-names>G</given-names></name></person-group><article-title>Genetic susceptibility to age-related macular degeneration: a paradigm for dissecting complex disease traits.</article-title><source>Hum Mol Genet</source><year>2007</year><volume>16</volume><fpage>R174</fpage><lpage>82</lpage><pub-id pub-id-type="pmid">17911160</pub-id></citation></ref><ref id="r36"><label>36</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>JM</given-names></name><name><surname>Wan</surname><given-names>L</given-names></name><name><surname>Tsai</surname><given-names>YY</given-names></name><name><surname>Lin</surname><given-names>HJ</given-names></name><name><surname>Tsai</surname><given-names>Y</given-names></name><name><surname>Lee</surname><given-names>CC</given-names></name><name><surname>Tsai</surname><given-names>CH</given-names></name><name><surname>Tseng</surname><given-names>SH</given-names></name><name><surname>Tsai</surname><given-names>FJ</given-names></name></person-group><article-title>Pigment epithelium-derived factor gene Met72Thr polymorphism is associated with increased risk of wet age-related macular degeneration.</article-title><source>Am J Ophthalmol</source><year>2008</year><volume>145</volume><fpage>716</fpage><lpage>21</lpage><pub-id pub-id-type="pmid">18226801</pub-id></citation></ref><ref id="r37"><label>37</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zarbin</surname><given-names>MA</given-names></name></person-group><article-title>Current concepts in the pathogenesis of age-related macular degeneration.</article-title><source>Arch Ophthalmol</source><year>2004</year><volume>122</volume><fpage>598</fpage><lpage>614</lpage><pub-id pub-id-type="pmid">15078679</pub-id></citation></ref><ref id="r38"><label>38</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mattes</surname><given-names>D</given-names></name><name><surname>Haas</surname><given-names>A</given-names></name><name><surname>Renner</surname><given-names>W</given-names></name><name><surname>Steinbrugger</surname><given-names>I</given-names></name><name><surname>El-Shabrawi</surname><given-names>Y</given-names></name><name><surname>Wedrich</surname><given-names>A</given-names></name><name><surname>Werner</surname><given-names>C</given-names></name><name><surname>Schmut</surname><given-names>O</given-names></name><name><surname>Weger</surname><given-names>M</given-names></name></person-group><article-title>Analysis of three pigment epithelium-derived factor gene polymorphisms in patients with exudative age-related macular degeneration.</article-title><source>Mol Vis</source><year>2009</year><volume>15</volume><fpage>343</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">19223990</pub-id></citation></ref><ref id="r39"><label>39</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Edwards</surname><given-names>AO</given-names></name><name><surname>Chen</surname><given-names>D</given-names></name><name><surname>Fridley</surname><given-names>BL</given-names></name><name><surname>James</surname><given-names>KM</given-names></name><name><surname>Wu</surname><given-names>Y</given-names></name><name><surname>Abecasis</surname><given-names>G</given-names></name><name><surname>Swaroop</surname><given-names>A</given-names></name><name><surname>Othman</surname><given-names>M</given-names></name><name><surname>Branham</surname><given-names>K</given-names></name><name><surname>Iyengar</surname><given-names>SK</given-names></name><name><surname>Sivakumaran</surname><given-names>TA</given-names></name><name><surname>Klein</surname><given-names>R</given-names></name><name><surname>Klein</surname><given-names>BE</given-names></name><name><surname>Tosakulwong</surname><given-names>N</given-names></name></person-group><article-title>Toll-like receptor polymorphisms and age-related macular degeneration.</article-title><source>Invest Ophthalmol Vis Sci</source><year>2008</year><volume>49</volume><fpage>1652</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">18385087</pub-id></citation></ref><ref id="r40"><label>40</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kondo</surname><given-names>N</given-names></name><name><surname>Honda</surname><given-names>S</given-names></name><name><surname>Kuno</surname><given-names>S</given-names></name><name><surname>Negi</surname><given-names>A</given-names></name></person-group><article-title>Coding variant I62V in the complement factor H gene is strongly associated with polypoidal choroidal vasculopathy.</article-title><source>Ophthalmology</source><year>2009</year><volume>116</volume><fpage>304</fpage><lpage>10</lpage><pub-id pub-id-type="pmid">19187823</pub-id></citation></ref><ref id="r41"><label>41</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Seddon</surname><given-names>JM</given-names></name><name><surname>Sharma</surname><given-names>S</given-names></name><name><surname>Adelman</surname><given-names>RA</given-names></name></person-group><article-title>Evaluation of the clinical age-related maculopathy staging system.</article-title><source>Ophthalmology</source><year>2006</year><volume>113</volume><fpage>260</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">16458093</pub-id></citation></ref><ref id="r42"><label>42</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wigginton</surname><given-names>JE</given-names></name><name><surname>Cutler</surname><given-names>DJ</given-names></name><name><surname>Abecasis</surname><given-names>GR</given-names></name></person-group><article-title>A note on exact tests of Hardy-Weinberg equilibrium.</article-title><source>Am J Hum Genet</source><year>2005</year><volume>76</volume><fpage>887</fpage><lpage>93</lpage><pub-id pub-id-type="pmid">15789306</pub-id></citation></ref><ref id="r43"><label>43</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Balding</surname><given-names>DJ</given-names></name></person-group><article-title>A tutorial on statistical methods for population association studies.</article-title><source>Nat Rev Genet</source><year>2006</year><volume>7</volume><fpage>781</fpage><lpage>91</lpage><pub-id pub-id-type="pmid">16983374</pub-id></citation></ref><ref id="r44"><label>44</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Purcell</surname><given-names>S</given-names></name><name><surname>Neale</surname><given-names>B</given-names></name><name><surname>Todd-Brown</surname><given-names>K</given-names></name><name><surname>Thomas</surname><given-names>L</given-names></name><name><surname>Ferreira</surname><given-names>MA</given-names></name><name><surname>Bender</surname><given-names>D</given-names></name><name><surname>Maller</surname><given-names>J</given-names></name><name><surname>Sklar</surname><given-names>P</given-names></name><name><surname>de Bakker</surname><given-names>PI</given-names></name><name><surname>Daly</surname><given-names>MJ</given-names></name><name><surname>Sham</surname><given-names>PC</given-names></name></person-group><article-title>PLINK: a tool set for whole-genome association and population-based linkage analyses.</article-title><source>Am J Hum Genet</source><year>2007</year><volume>81</volume><fpage>559</fpage><lpage>75</lpage><pub-id pub-id-type="pmid">17701901</pub-id></citation></ref><ref id="r45"><label>45</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gauderman</surname><given-names>WJ</given-names></name></person-group><article-title>Sample size requirements for matched case-control studies of gene-environment interaction.</article-title><source>Stat Med</source><year>2002</year><volume>21</volume><fpage>35</fpage><lpage>50</lpage><pub-id pub-id-type="pmid">11782049</pub-id></citation></ref><ref id="r46"><label>46</label><citation citation-type="journal"><person-group person-group-type="author"><collab>The International HapMap Project</collab></person-group><source>Nature</source><year>2003</year><volume>426</volume><fpage>789</fpage><lpage>96</lpage><pub-id pub-id-type="pmid">14685227</pub-id></citation></ref><ref id="r47"><label>47</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Barrett</surname><given-names>JC</given-names></name><name><surname>Fry</surname><given-names>B</given-names></name><name><surname>Maller</surname><given-names>J</given-names></name><name><surname>Daly</surname><given-names>MJ</given-names></name></person-group><article-title>Haploview: analysis and visualization of LD and haplotype maps.</article-title><source>Bioinformatics</source><year>2005</year><volume>21</volume><fpage>263</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">15297300</pub-id></citation></ref><ref id="r48"><label>48</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Marchini</surname><given-names>J</given-names></name><name><surname>Cardon</surname><given-names>LR</given-names></name><name><surname>Phillips</surname><given-names>MS</given-names></name><name><surname>Donnelly</surname><given-names>P</given-names></name></person-group><article-title>The effects of human population structure on large genetic association studies.</article-title><source>Nat Genet</source><year>2004</year><volume>36</volume><fpage>512</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">15052271</pub-id></citation></ref><ref id="r49"><label>49</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Falush</surname><given-names>D</given-names></name><name><surname>Stephens</surname><given-names>M</given-names></name><name><surname>Pritchard</surname><given-names>JK</given-names></name></person-group><article-title>Inference of population structure using multilocus genotype data: linked loci and correlated allele frequencies.</article-title><source>Genetics</source><year>2003</year><volume>164</volume><fpage>1567</fpage><lpage>87</lpage><pub-id pub-id-type="pmid">12930761</pub-id></citation></ref><ref id="r50"><label>50</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kubo</surname><given-names>M</given-names></name><name><surname>Hata</surname><given-names>J</given-names></name><name><surname>Ninomiya</surname><given-names>T</given-names></name><name><surname>Matsuda</surname><given-names>K</given-names></name><name><surname>Yonemoto</surname><given-names>K</given-names></name><name><surname>Nakano</surname><given-names>T</given-names></name><name><surname>Matsushita</surname><given-names>T</given-names></name><name><surname>Yamazaki</surname><given-names>K</given-names></name><name><surname>Ohnishi</surname><given-names>Y</given-names></name><name><surname>Saito</surname><given-names>S</given-names></name><name><surname>Kitazono</surname><given-names>T</given-names></name><name><surname>Ibayashi</surname><given-names>S</given-names></name><name><surname>Sueishi</surname><given-names>K</given-names></name><name><surname>Iida</surname><given-names>M</given-names></name><name><surname>Nakamura</surname><given-names>Y</given-names></name><name><surname>Kiyohara</surname><given-names>Y</given-names></name></person-group><article-title>A nonsynonymous SNP in PRKCH (protein kinase C eta) increases the risk of cerebral infarction.</article-title><source>Nat Genet</source><year>2007</year><volume>39</volume><fpage>212</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">17206144</pub-id></citation></ref><ref id="r51"><label>51</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yamada</surname><given-names>K</given-names></name><name><surname>Gerber</surname><given-names>DJ</given-names></name><name><surname>Iwayama</surname><given-names>Y</given-names></name><name><surname>Ohnishi</surname><given-names>T</given-names></name><name><surname>Ohba</surname><given-names>H</given-names></name><name><surname>Toyota</surname><given-names>T</given-names></name><name><surname>Aruga</surname><given-names>J</given-names></name><name><surname>Minabe</surname><given-names>Y</given-names></name><name><surname>Tonegawa</surname><given-names>S</given-names></name><name><surname>Yoshikawa</surname><given-names>T</given-names></name></person-group><article-title>Genetic analysis of the calcineurin pathway identifies members of the EGR gene family, specifically EGR3, as potential susceptibility candidates in schizophrenia.</article-title><source>Proc Natl Acad Sci USA</source><year>2007</year><volume>104</volume><fpage>2815</fpage><lpage>20</lpage><pub-id pub-id-type="pmid">17360599</pub-id></citation></ref><ref id="r52"><label>52</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pritchard</surname><given-names>JK</given-names></name><name><surname>Stephens</surname><given-names>M</given-names></name><name><surname>Donnelly</surname><given-names>P</given-names></name></person-group><article-title>Inference of population structure using multilocus genotype data.</article-title><source>Genetics</source><year>2000</year><volume>155</volume><fpage>945</fpage><lpage>59</lpage><pub-id pub-id-type="pmid">10835412</pub-id></citation></ref><ref id="r53"><label>53</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Karakousis</surname><given-names>PC</given-names></name><name><surname>John</surname><given-names>SK</given-names></name><name><surname>Behling</surname><given-names>KC</given-names></name><name><surname>Surace</surname><given-names>EM</given-names></name><name><surname>Smith</surname><given-names>JE</given-names></name><name><surname>Hendrickson</surname><given-names>A</given-names></name><name><surname>Tang</surname><given-names>WX</given-names></name><name><surname>Bennett</surname><given-names>J</given-names></name><name><surname>Milam</surname><given-names>AH</given-names></name></person-group><article-title>Localization of pigment epithelium derived factor (PEDF) in developing and adult human ocular tissues.</article-title><source>Mol Vis</source><year>2001</year><volume>7</volume><fpage>154</fpage><lpage>63</lpage><pub-id pub-id-type="pmid">11438800</pub-id></citation></ref><ref id="r54"><label>54</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chader</surname><given-names>GJ</given-names></name></person-group><article-title>PEDF: Raising both hopes and questions in controlling angiogenesis.</article-title><source>Proc Natl Acad Sci USA</source><year>2001</year><volume>98</volume><fpage>2122</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">11226201</pub-id></citation></ref><ref id="r55"><label>55</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dawson</surname><given-names>DW</given-names></name><name><surname>Volpert</surname><given-names>OV</given-names></name><name><surname>Gillis</surname><given-names>P</given-names></name><name><surname>Crawford</surname><given-names>SE</given-names></name><name><surname>Xu</surname><given-names>H</given-names></name><name><surname>Benedict</surname><given-names>W</given-names></name><name><surname>Bouck</surname><given-names>NP</given-names></name></person-group><article-title>Pigment epithelium-derived factor: a potent inhibitor of angiogenesis.</article-title><source>Science</source><year>1999</year><volume>285</volume><fpage>245</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">10398599</pub-id></citation></ref><ref id="r56"><label>56</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Holekamp</surname><given-names>NM</given-names></name><name><surname>Bouck</surname><given-names>N</given-names></name><name><surname>Volpert</surname><given-names>O</given-names></name></person-group><article-title>Pigment epithelium-derived factor is deficient in the vitreous of patients with choroidal neovascularization due to age-related macular degeneration.</article-title><source>Am J Ophthalmol</source><year>2002</year><volume>134</volume><fpage>220</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">12140029</pub-id></citation></ref><ref id="r57"><label>57</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bhutto</surname><given-names>IA</given-names></name><name><surname>Uno</surname><given-names>K</given-names></name><name><surname>Merges</surname><given-names>C</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>McLeod</surname><given-names>DS</given-names></name><name><surname>Lutty</surname><given-names>GA</given-names></name></person-group><article-title>Reduction of endogenous angiogenesis inhibitors in Bruch's membrane of the submacular region in eyes with age-related macular degeneration.</article-title><source>Arch Ophthalmol</source><year>2008</year><volume>126</volume><fpage>670</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">18474778</pub-id></citation></ref><ref id="r58"><label>58</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mori</surname><given-names>K</given-names></name><name><surname>Gehlbach</surname><given-names>P</given-names></name><name><surname>Yamamoto</surname><given-names>S</given-names></name><name><surname>Duh</surname><given-names>E</given-names></name><name><surname>Zack</surname><given-names>DJ</given-names></name><name><surname>Li</surname><given-names>Q</given-names></name><name><surname>Berns</surname><given-names>KI</given-names></name><name><surname>Raisler</surname><given-names>BJ</given-names></name><name><surname>Hauswirth</surname><given-names>WW</given-names></name><name><surname>Campochiaro</surname><given-names>PA</given-names></name></person-group><article-title>AAV-mediated gene transfer of pigment epithelium-derived factor inhibits choroidal neovascularization.</article-title><source>Invest Ophthalmol Vis Sci</source><year>2002</year><volume>43</volume><fpage>1994</fpage><lpage>2000</lpage><pub-id pub-id-type="pmid">12037010</pub-id></citation></ref><ref id="r59"><label>59</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mori</surname><given-names>K</given-names></name><name><surname>Gehlbach</surname><given-names>P</given-names></name><name><surname>Ando</surname><given-names>A</given-names></name><name><surname>McVey</surname><given-names>D</given-names></name><name><surname>Wei</surname><given-names>L</given-names></name><name><surname>Campochiaro</surname><given-names>PA</given-names></name></person-group><article-title>Regression of ocular neovascularization in response to increased expression of pigment epithelium-derived factor.</article-title><source>Invest Ophthalmol Vis Sci</source><year>2002</year><volume>43</volume><fpage>2428</fpage><lpage>34</lpage><pub-id pub-id-type="pmid">12091447</pub-id></citation></ref><ref id="r60"><label>60</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Campochiaro</surname><given-names>PA</given-names></name><name><surname>Nguyen</surname><given-names>QD</given-names></name><name><surname>Shah</surname><given-names>SM</given-names></name><name><surname>Klein</surname><given-names>ML</given-names></name><name><surname>Holz</surname><given-names>E</given-names></name><name><surname>Frank</surname><given-names>RN</given-names></name><name><surname>Saperstein</surname><given-names>DA</given-names></name><name><surname>Gupta</surname><given-names>A</given-names></name><name><surname>Stout</surname><given-names>JT</given-names></name><name><surname>Macko</surname><given-names>J</given-names></name><name><surname>DiBartolomeo</surname><given-names>R</given-names></name><name><surname>Wei</surname><given-names>LL</given-names></name></person-group><article-title>Adenoviral vector-delivered pigment epithelium-derived factor for neovascular age-related macular degeneration: results of a phase I clinical trial.</article-title><source>Hum Gene Ther</source><year>2006</year><volume>17</volume><fpage>167</fpage><lpage>76</lpage><pub-id pub-id-type="pmid">16454650</pub-id></citation></ref><ref id="r61"><label>61</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Colhoun</surname><given-names>HM</given-names></name><name><surname>McKeigue</surname><given-names>PM</given-names></name><name><surname>Davey Smith</surname><given-names>G</given-names></name></person-group><article-title>Problems of reporting genetic associations with complex outcomes.</article-title><source>Lancet</source><year>2003</year><volume>361</volume><fpage>865</fpage><lpage>72</lpage><pub-id pub-id-type="pmid">12642066</pub-id></citation></ref><ref id="r62"><label>62</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>NCI-NHGRI Working Group on Replication in Association Studies</surname></name><name><surname>Chanock</surname><given-names>SJ</given-names></name><name><surname>Manolio</surname><given-names>T</given-names></name><name><surname>Boehnke</surname><given-names>M</given-names></name><name><surname>Boerwinkle</surname><given-names>E</given-names></name><name><surname>Hunter</surname><given-names>DJ</given-names></name><name><surname>Thomas</surname><given-names>G</given-names></name><name><surname>Hirschhorn</surname><given-names>JN</given-names></name><name><surname>Abecasis</surname><given-names>G</given-names></name><name><surname>Altshuler</surname><given-names>D</given-names></name><name><surname>Bailey-Wilson</surname><given-names>JE</given-names></name><name><surname>Brooks</surname><given-names>LD</given-names></name><name><surname>Cardon</surname><given-names>LR</given-names></name><name><surname>Daly</surname><given-names>M</given-names></name><name><surname>Donnelly</surname><given-names>P</given-names></name><name><surname>Fraumeni</surname><given-names>JF</given-names><suffix>Jr</suffix></name><name><surname>Freimer</surname><given-names>NB</given-names></name><name><surname>Gerhard</surname><given-names>DS</given-names></name><name><surname>Gunter</surname><given-names>C</given-names></name><name><surname>Guttmacher</surname><given-names>AE</given-names></name><name><surname>Guyer</surname><given-names>MS</given-names></name><name><surname>Harris</surname><given-names>EL</given-names></name><name><surname>Hoh</surname><given-names>J</given-names></name><name><surname>Hoover</surname><given-names>R</given-names></name><name><surname>Kong</surname><given-names>CA</given-names></name><name><surname>Merikangas</surname><given-names>KR</given-names></name><name><surname>Morton</surname><given-names>CC</given-names></name><name><surname>Palmer</surname><given-names>LJ</given-names></name><name><surname>Phimister</surname><given-names>EG</given-names></name><name><surname>Rice</surname><given-names>JP</given-names></name><name><surname>Roberts</surname><given-names>J</given-names></name><name><surname>Rotimi</surname><given-names>C</given-names></name><name><surname>Tucker</surname><given-names>MA</given-names></name><name><surname>Vogan</surname><given-names>KJ</given-names></name><name><surname>Wacholder</surname><given-names>S</given-names></name><name><surname>Wijsman</surname><given-names>EM</given-names></name><name><surname>Winn</surname><given-names>DM</given-names></name><name><surname>Collins</surname><given-names>FS</given-names></name></person-group><article-title>Replicating genotype-phenotype associations.</article-title><source>Nature</source><year>2007</year><volume>447</volume><fpage>655</fpage><lpage>60</lpage><pub-id pub-id-type="pmid">17554299</pub-id></citation></ref></ref-list></back></article> 